| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bvf Partners L P | 10% Owner | 2026-05-14 | 772,000 | $4.03 | $3.11MBuy |
| Bvf Partners L P | 10% Owner | 2026-05-14 | 2,313,000 | $4.03 | $9.32MBuy |
| Bvf Partners L P | 10% Owner | 2026-05-14 | 1,506,000 | $4.03 | $6.07MBuy |
| Bvf Partners L P | 10% Owner | 2026-05-14 | 412,000 | $4.03 | $1.66MBuy |
| Jeffrey Trigilio | Chief Financial Officer | 2026-04-13 | 1,632 | $36.76 | $59.99kSell |
| Joseph M. Limber | Director | 2026-03-27 | 3,026 | $11.20 | $33.89kBuy |
| Jack L. Wyszomierski | Director | 2026-03-24 | 3,026 | $11.20 | $33.89kBuy |
| Owen Hughes | Chief Executive Officer | 2025-12-04 | 100,000 | $25.05 | $2.51MBuy |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 15 | $36.81 | $552.15Sell |
| Thomas M. Burns | SVP Finance CFO | 2025-09-22 | 15 | $36.93 | $553.95Sell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Brothers Life Sciences Capital GP LLC | 108.49% | 13,606,093 | $565.20M | Insider |
| Baker Brothers Life Sciences LP | 108.49% | 13,606,093 | $565.20M | Insider |
| Bvf Inc | 20.65% | 2,590,303 | $107.60M | Institution |
| Morgan Stanley | 13.57% | 1,702,157 | $70.71M | Institution |
| Baker Biotech Capital GP LLC | 12.64% | 1,585,591 | $65.87M | Insider |
| 667 LP | 12.64% | 1,585,591 | $65.87M | Insider |
| Fmr LLC | 10.39% | 1,302,974 | $54.13M | Institution |
| Bvf Partners L P | 9.44% | 1,184,000 | $49.18M | Insider |
| Bvf GP Holdings LLC | 8.80% | 1,103,314 | $45.83M | Insider |
| Blackrock Inc | 5.16% | 646,914 | $26.87M | Institution |